PRO/AH/EDR> COVID-19 update (241): South Africa, beta variant, vaccines, Netherlands, WHO

COVID-19 — Worldwide/Unknown
COVID seroprevalence at the beginning of 2021 was 18.9% in 21 464 US patients who received dialysis, or roughly a rise of 15 percentage points compared with July 2020, according to a study yesterday [12 Jul 2021] in JAMA Network Open.
The researchers looked at 21 464 patients who received dialysis from US Renal Care facilities in January [2021], excluding people who had received COVID vaccinations. Less than 1 in 5 (18.4%) had COVID-19 antibodies, which translated to an 18.7% seroprevalence